The North America Neurovascular Devices Market should witness market growth of 8.1% CAGR during the forecast period (2022-2028).
The primary element driving the market's growth is the increase in the elderly population. In addition, other elements, including the upsurge in the use of neurovascular devices and the rise in the prevalence of neurovascular disorders, support market expansion. Furthermore, the market for neurovascular devices is also growing for additional reasons, such as the explosion in technological breakthroughs linked to these devices. Also, participants in the neurovascular devices market have lucrative potential owing to the rapid development rates displayed by developing countries.
The market is anticipated to experience growth during the forecast period because of the increasing incidence of neurological conditions and the increasing adoption of neurovascular devices for diagnosing and treating ailments. Neurovascular conditions, such as brain aneurysms, carotid artery disease,arteriovenous malformations (AVMs), and intracranial atherosclerotic disease, significantly negatively impact health and the world economy. These conditions can lead to neurological issues, including subarachnoid hemorrhage, stroke, disability, and even death.
In the United States, stroke is the main factor responsible for most of the long-term disabilities. According to CDC statistics, one in six cardiovascular disease-related fatalities in 2020 was caused by stroke. Around 87% of all strokes were ischemic strokes, in which the blood supply to the brain is blocked. Throughout 2017 and 2018, the cost of stroke in the United States was over $53 billion. Stroke is primarily brought on by high blood pressure, smoking, high cholesterol, obesity, and diabetes. At least one of the aforementioned conditions or behaviors affects one in three adults in the United States.
The US market dominated the North America Neurovascular Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,119.7 million by 2028. The Canada market is poised to grow at a CAGR of 10.5% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 9.6% during (2022-2028).
Based on End-user, the market is segmented into Hospital & Surgery Centers, Ambulatory Care Centers and Research laboratories & Academic Institutes. Based on Technology, the market is segmented into Embolization & Coiling (Embolic Coils, Flow Diversion Devices and Liquid Embolic Agents), Neurothrombectomy Devices (Clot Retrievers, Suction & Aspiration Devices, and Snares), Cerebral Balloon Angioplasty & Stenting Systems (Carotid Artery Stents and Embolic Protection Systems), and Support Devices (Microcatheters and Microguidewires). Based on Disease Pathology, the market is segmented into Cerebral Aneuryms, Ischemic Strokes, Cartoid Artery Stenosis, Arteriovenous Malformation & Fistulas (AVM) and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Stryker Corporation, Johnson & Johnson, Terumo Corporation, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Medikit Co. Ltd., and W. L. Gore & Associates, Inc.
The primary element driving the market's growth is the increase in the elderly population. In addition, other elements, including the upsurge in the use of neurovascular devices and the rise in the prevalence of neurovascular disorders, support market expansion. Furthermore, the market for neurovascular devices is also growing for additional reasons, such as the explosion in technological breakthroughs linked to these devices. Also, participants in the neurovascular devices market have lucrative potential owing to the rapid development rates displayed by developing countries.
The market is anticipated to experience growth during the forecast period because of the increasing incidence of neurological conditions and the increasing adoption of neurovascular devices for diagnosing and treating ailments. Neurovascular conditions, such as brain aneurysms, carotid artery disease,arteriovenous malformations (AVMs), and intracranial atherosclerotic disease, significantly negatively impact health and the world economy. These conditions can lead to neurological issues, including subarachnoid hemorrhage, stroke, disability, and even death.
In the United States, stroke is the main factor responsible for most of the long-term disabilities. According to CDC statistics, one in six cardiovascular disease-related fatalities in 2020 was caused by stroke. Around 87% of all strokes were ischemic strokes, in which the blood supply to the brain is blocked. Throughout 2017 and 2018, the cost of stroke in the United States was over $53 billion. Stroke is primarily brought on by high blood pressure, smoking, high cholesterol, obesity, and diabetes. At least one of the aforementioned conditions or behaviors affects one in three adults in the United States.
The US market dominated the North America Neurovascular Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,119.7 million by 2028. The Canada market is poised to grow at a CAGR of 10.5% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 9.6% during (2022-2028).
Based on End-user, the market is segmented into Hospital & Surgery Centers, Ambulatory Care Centers and Research laboratories & Academic Institutes. Based on Technology, the market is segmented into Embolization & Coiling (Embolic Coils, Flow Diversion Devices and Liquid Embolic Agents), Neurothrombectomy Devices (Clot Retrievers, Suction & Aspiration Devices, and Snares), Cerebral Balloon Angioplasty & Stenting Systems (Carotid Artery Stents and Embolic Protection Systems), and Support Devices (Microcatheters and Microguidewires). Based on Disease Pathology, the market is segmented into Cerebral Aneuryms, Ischemic Strokes, Cartoid Artery Stenosis, Arteriovenous Malformation & Fistulas (AVM) and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Stryker Corporation, Johnson & Johnson, Terumo Corporation, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Medikit Co. Ltd., and W. L. Gore & Associates, Inc.
Scope of the Study
By End-user
- Hospital & Surgery Centers
- Ambulatory Care Centers
- Research laboratories & Academic Institutes
By Technology
- Embolization & Coiling
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Neurothrombectomy Devices
- Clot Retrievers
- Suction & Aspiration Devices
- Snares
- Cerebral Balloon Angioplasty & Stenting Systems
- Carotid Artery Stents
- Embolic Protection Systems
- Support Devices
- Microcatheters
- Microguidewires
By Disease Pathology
- Cerebral Aneuryms
- Ischemic Strokes
- Cartoid Artery Stenosis
- Arteriovenous Malformation & Fistulas (AVM)
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Medtronic PLC
- Stryker Corporation
- Johnson & Johnson
- Terumo Corporation
- Merit Medical Systems, Inc.
- MicroPort Scientific Corporation
- Medikit Co. Ltd.
- W. L. Gore & Associates, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. North America Neurovascular Devices Market by End-user
Chapter 4. North America Neurovascular Devices Market by Technology
Chapter 5. North America Neurovascular Devices Market by Disease Pathology
Chapter 6. North America Neurovascular Devices Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Abbott Laboratories
- Medtronic PLC
- Stryker Corporation
- Johnson & Johnson
- Terumo Corporation
- Merit Medical Systems, Inc.
- MicroPort Scientific Corporation
- Medikit Co. Ltd.
- W. L. Gore & Associates, Inc.
Methodology
LOADING...
Related Reports
Global Neurovascular Devices Market by Disease Pathology, Devices, End-User - Forecast 2024-2030
- Report
- 197 Pages
- Global
From
From
Global Neurovascular Devices Market Analysis & Forecast to 2024-2034
- Report
- 200 Pages
- Global
From
Global Neurovascular Devices Market Report and Forecast 2023-2031
- Report
- 160 Pages
- Global
From
About the Neurovascular Device Market
The Neurovascular Device market is a subset of the Neurology Devices market, which focuses on the diagnosis and treatment of neurological disorders. Neurovascular Devices are used to treat conditions such as stroke, aneurysms, and arteriovenous malformations. These devices are used to restore blood flow to the brain, reduce the risk of stroke, and improve patient outcomes. Neurovascular Devices include stents, embolic coils, flow diverters, and occlusion balloons. These devices are used in a variety Read more
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF. 
